-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Raltitrexed is a chemotherapy drug used to treat various types of cancer, including colorectal cancer, breast cancer, and lung cancer.
The drug is a derivative of the natural product, belotecan, which is obtained from the leaves of the rosy periwinkle plant (Catharanthus roseus).
Raltitrexed is synthesized through several stages, with the final product being a semisynthetic derivative of belotecan.
The synthetic route of raltitrexed involves several chemical reactions, including deprotection, condensation, and reduction steps.
In this article, we will discuss the synthetic routes of raltitrexed, including the various chemical reactions involved in its synthesis.
The synthetic route to raltitrexed typically involves several steps.
The first step involves the synthesis of the natural product, belotecan.
This is typically achieved through a series of chemical reactions, including extraction, chromatography, and oxidation steps.
The belotecan molecule is then subjected to deprotection reactions, which involve the removal of protecting groups that were added during the synthesis process.
The next step in the synthetic route of raltitrexed is the condensation of the belotecan molecule with a suitable condensing agent, such as acetic anhydride or dichloroacetic acid.
This step is important for the formation of the final product, raltitrexed.
The condensation reaction is typically carried out in the presence of a base, such as sodium hydroxide, to neutralize the acidic condensing agent.
After the condensation reaction, the molecule is subjected to a series of reduction steps to reduce the carboxyl groups to alcohol groups.
The reduction steps typically involve the use of reducing agents, such as lithium aluminum hydride or hydrogen in the presence of a noble metal catalyst, such as palladium or platinum.
The reduction steps are followed by deprotection reactions to remove the protecting groups added during the synthesis process.
The final product, raltitrexed, is then isolated from the reaction mixture using standard chromatography and purification techniques.
It is important to note that the synthetic route to raltitrexed may vary depending on the manufacturer and the specific conditions used.
Additionally, the use of hazardous reagents, such as dimethyl sulfate or hydrogen sulfide, is sometimes necessary during the synthesis process.
In conclusion, the synthetic route to raltitrexed involves several chemical reactions, including deprotection, condensation, and reduction steps.
The final product is a semisynthetic derivative of belotecan, which is obtained from the natural product rosy periwinkle.
The synthetic route to raltitrexed may vary depending on the manufacturer and the specific conditions used, and the use of hazardous reagents may sometimes be necessary.
Nonetheless, the synthetic route to raltitrexed is a well-established process that has been used for many years to produce this important chemotherapy drug.